Blood Journal | Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

Posted: September 16, 2014 in Cancer, Cannabis, health, hemp, Marijuana
Tags: , , , , ,

Blood Journal | Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s